Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the standalone and consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has informed BSE that its Board of Directors will meet on Wednesday, 13th August 2025, at its registered office in Delhi. The main item on the agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025 (Q1FY26). The meeting may also consider any other business matter with the Chair's permission. In line with insider trading rules, the trading window for designated persons remains closed and will reopen 48 hours after the results are declared.
This is a routine regulatory filing ahead of the company's quarterly earnings announcement. Shareholders should watch for the Q1FY26 results on or after 13th August 2025; no immediate price catalyst is expected from the intimation itself.